Experts Skeptical As Russia’s COVID-19 Vaccine Outshines Pfizer Results

Efficacy Of 92% Claimed For Sputnik V

Russia Sputnik Vaccine
Russia claimed the world's first COVID-19 vaccine approval in August - and has now claimed superiority to Pfizer's candidate in interim results.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D